CAR-T cell therapy is an emerging treatment currently being investigated in clinical trials for Multiple Sclerosis. But what exactly is CAR-T cell therapy, and why is cell-based therapy important in MS treatment? Join neurologist Dr. Bermel as he delves into the science behind this innovative cell-based therapy and discusses what answers clinical trial investigators are looking to find during their research.
Thank you to our sponsors, Bristol Myers Squibb and Kyverna, for making this content possible.
Learn more at www.cando-ms.org
Subscribe to Can Do MS! / @mscandoorg